dsdsa

product

Factory wholesale Osimertinib - High Purity Ready Stock 61825-94-3 Oxaliplatin for Platinum Anticancer Drugs – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

Our purpose would be to offer good quality products at competitive price ranges, and top-notch support to clients around the whole world. We're ISO9001, CE, and GS certified and strictly adhere to their good quality specifications for China Lose Weight Cetilistat, Favipiravir, Ruxolitinib Powder, "Quality first, Price lowest, Service best" is the spirit of our company. We sincerely welcome you to visit our company and negotiate mutual business!
Factory wholesale Osimertinib - High Purity Ready Stock 61825-94-3 Oxaliplatin for Platinum Anticancer Drugs – Yibai Detail:

Product name Oxaliplatin
Synonyms trans-L-Diaminocyclohexane oxalatoplatinum
CAS No. 61825-94-3
Appearance White to off white crystallization powder
Molecular Formula C8H12N2O4Pt
Molecular Weight 395.27
Usage Pharmaceutical Grade or Research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

Oxaliplatin Cas: 61825-94-3

Items

Standard

Results

Appearance White or almost white crystalline powder White crystalline powder
Solubility Slightly soluble in water ,very slightly soluble in methanol, practically insoluble in anhydrous ethanol Complies
Identification   Spectrum of sample should consistent with spectrum of reference standard A.CompliesB.Complies
Apearance of solution The solution is clear and colourless Complies
Acidity Not more than 0.6ml of 0.01M NaOH is required to change the colour of the indicator to pink Complies
Specific optical rotation +74.5°~+78.0° +75.9°
Related substances ImpurityA:NMT0.10%ImpurityB: NMT0.10%

ImpurityC: NMT0.10%

Any other impurity:NMT0.10%

Total of other impurities: NMT0.10%

(include impurity C)                     

Total of impurities: NMT0.30%

ImpurityA: 0.04%  ImpurityB:0.01%ImpurityC: 0.001%

Any other impurities: 0.002%

Total of other impurities:

0.01%

Total of impurities: 0.03%

Impurity D NMT0.10% N.D
Silver NMT5.0ppm 0.08ppm
Loss on drying NMT0.5% 0.09%
Assay 98.0~102.0% (dried substance) 99.7%
Conclusion: The results show that the product complies with EP9.0

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

Factory wholesale Osimertinib - High Purity Ready Stock  61825-94-3 Oxaliplatin for Platinum Anticancer Drugs – Yibai detail pictures

Factory wholesale Osimertinib - High Purity Ready Stock  61825-94-3 Oxaliplatin for Platinum Anticancer Drugs – Yibai detail pictures

Factory wholesale Osimertinib - High Purity Ready Stock  61825-94-3 Oxaliplatin for Platinum Anticancer Drugs – Yibai detail pictures


Related Product Guide:

Bear "Customer first, Quality first" in mind, we work closely with our customers and provide them with efficient and professional services for Factory wholesale Osimertinib - High Purity Ready Stock 61825-94-3 Oxaliplatin for Platinum Anticancer Drugs – Yibai , The product will supply to all over the world, such as: Tunisia, Croatia, Milan, Our company always committed to meet your quality demand, price points and sales target. Warmly welcome you open the boundaries of communication. It is our great pleasure to service you if you need a trusted supplier and value information.
  • It is really lucky to meet such a good supplier, this is our most satisfied cooperation, I think we will work again!
    5 Stars By Amy from Panama - 2017.02.14 13:19
    The customer service staff's answer is very meticulous, the most important is that the product quality is very good, and packaged carefully, shipped quickly!
    5 Stars By Mark from Venezuela - 2018.09.29 13:24
    Write your message here and send it to us